Showing results (1-10 of 384) with videos related to
Sort By:
Pageof 39
Biomolecules|May 24, 2020
Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and IdentityJavier A MenendezAging|May 29, 2020
Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19Javier A MenendezEuropean Journal of Pediatrics|December 14, 1999
Abnormal ventilatory responses in patients with Prader-Willi syndromeA A MenendezBiochimica Et Biophysica Acta|September 29, 2009
Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectivesJavier A MenendezCurrent Pharmaceutical Design|July 14, 2015
The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology DrugsJavier A MenendezCell Cycle (Georgetown, Tex.)|March 5, 2015
Metabolic control of cancer cell stemness: Lessons from iPS cellsJavier A MenendezExpert Opinion on Therapeutic Targets|September 19, 2017
Fatty acid synthase (FASN) as a therapeutic target in breast cancerJavier A Menendez, Ruth LupuInternational Journal of Molecular Medicine|December 8, 2004
RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cellsJavier A Menendez, Ruth LupuEndocrinology|July 1, 2006
Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?Ruth Lupu, Javier A MenendezCurrent Pharmaceutical Biotechnology|December 16, 2006
Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?Ruth Lupu, Javier A MenendezPageof 39